Campbell & Co Investment Adviser’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Sell |
48,397
-262
| -0.5% | -$3.54K | 0.04% | 683 |
|
|
2025
Q1 | $421K | Buy |
48,659
+17,448
| +56% | +$151K | 0.03% | 750 |
|
|
2024
Q4 | $152K | Sell |
31,211
-13,618
| -30% | -$66.2K | 0.01% | 995 |
|
|
2024
Q3 | $346K | Buy |
44,829
+19,016
| +74% | +$147K | 0.03% | 847 |
|
|
2024
Q2 | $258K | Buy |
+25,813
| New | +$258K | 0.02% | 887 |
|
|
2023
Q2 | – | Sell |
-20,620
| Closed | -$302K | – | 1056 |
|
|
2023
Q1 | $302K | Buy |
+20,620
| New | +$302K | 0.06% | 601 |
|
|
2022
Q1 | – | Sell |
-7,100
| Closed | -$441K | – | 848 |
|
|
2021
Q4 | $441K | Sell |
7,100
-4,400
| -38% | -$273K | 0.15% | 234 |
|
|
2021
Q3 | $984K | Buy |
11,500
+5,600
| +95% | +$479K | 0.32% | 66 |
|
|
2021
Q2 | $365K | Buy |
+5,900
| New | +$365K | 0.15% | 254 |
|